About this trial
This study is a prospective, randomized controlled clinical trial aimed at investigating the efficacy and safety of a novel oxygenating video laryngoscope blade during apneic oxygenation for intubation under general anesthesia. Hypoxemia is prone to occur during anesthesia induction, which can lead to severe complications. Apneic oxygenation is an important method to prolong the safe apnea time, but existing oxygen delivery modalities have limitations in applicability. Although the laryngeal oxygen delivery approach combined with video laryngoscopy has theoretical advantages, clinical evidence is insufficient. Therefore, this study was conducted.
Eligibility criteria
Qualifiers
Patients aged between 18 and 75 years, with ASA physical status I to III, and scheduled for surgery with general anaesthesia and orotracheal intubation
Disqualifiers
cardiac disease (ischaemic heart disease, heart failure [NYHA ≥2 ],current arrhythmias, pulmonary hypertension)
severe asthma, moderate to severe chronic obstructive pulmonary disease
pregnancy
baseline oxygen saturation <95%
Trial design
Treatments tested in this trial
- control group (Group C)
- The continuous laryngeal oxygen supply group (Group B)
Treatment groups
Locations
Sponsors and collaborators
Affiliated Hospital of Jiaxing University
Lead sponsor
The Second Affiliated Hospital of Jiaxing University
Sponsor institution
The Second Affiliated Hospital of Jiaxing University
Collaborator